Big Pharma and Monopoly Capitalism: A Long-term View

Are IPRs institutions meant to foster innovative activities or conversely to se- cure appropriation and profitability? Taking stock of a long-term empirical evidence on the pharmaceutical sector in the US, we can hardly support IPRs in- tended as an innovation rewarding institution.